Abstract
Shock-wave therapy (SWT) has been recognized as a viable treatment modality for select clinical indications since the early 1980’s, when it was predominantly used as a minimally invasive therapy for nephroureteral calculi. Soon after, SWT was found to stimulate angiogenesis in hypovascularized structures and became increasingly utilized for various orthopedic indications. However, it was not until 2010, when Vardi, Gruenwald and colleagues published their 6-month pilot data on the use of low-intensity SWT (LiSWT) to treat erectile dysfunction (ED) when LiSWT became increasingly popularized for sexual medicine indications.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
